Subscribe

By Peter Gilmore

Articles by By Peter Gilmore

Specialty drug market access reality check

ByBy Peter Gilmore,Amy Hunckler, KPMG Strategy

September 1st 2016

Ten payer pressures to act on now

Latest Updated Articles

Specialty drug market access reality check
September 1st 2016

Trending on Pharmaceutical Commerce

What Trutakna's Approval Means for Specialty Launches

FAQ: Where US Pharma Reshoring Stands in 2026

Deanna Horner's Five-Year Outlook for Direct-to-Patient Care

Building Durability in Rare Disease Care With PANTHERx Rare

What Makes Patient Support Programs Work, and What Doesn't